For application purposes, if a patient with operable ESCC is with high expression of Skp2, adjuvant chemotherapy can be recommended after surgery; on the contrary, for patients with a low expression of Skp2, observation is preferred. The gene discussed is SKP2; the disease is esophageal squamous cell carcinoma.